Selecting and Dosing Clotting Factors to Individualize Treatment for Patients with Hemophilia A

Access Activity

Overview / Abstract:

Target Audience

This initiative is intended for hemophilia specialists, hematologists, emergency department clinicians, nurses, medical geneticists, genetic counselors, and other healthcare providers who care for patients with hemophilia A.

Program Overview

Hemophilia A is an inherited bleeding disorders due to the partial or total deficiency of coagulation factor (F) VIII. Progress in hemophilia therapy has been remarkable over the last decades with the development of efficacious therapies and extended half-life products based on prophylactic replacement of FVIII and improved understanding of the management of inhibitory antibodies to infused factor and the potential for gene therapy as a therapeutic option.

These activities will review the management of hemophilia A and examine the role of current and emerging therapeutic recommendations. Case vignettes will be presented to highlight the hematology care team’s role in the management of hemophilia A along with the importance of using shared decision-making strategies to help with patient and/or caregiver adherence to treatment plans.

Learning Objectives

Upon completion of this activity, participants should be better able to:

Compare available and emerging clotting factor treatments for patients with hemophilia A
Describe clinical factors that influence treatment selection and specific dosing protocols
Develop individualized prophylactic treatment plans for hemophilia A, including factor selection and dosing


Feb 01, 2023


Physician CME



Credits / Hours

0.5 AMA PRA Category 1 Credit(s)™



Presenters / Authors / Faculty


Guy Young, MD
Director, Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
Professor of Pediatrics (Clinical Scholar)
Keck School of Medicine
University of Southern California
Los Angeles, CA

Sponsors / Supporters / Grant Providers

Sanofi Genzyme and Takeda Pharmaceuticals U.S.A., Inc.

Keywords / Search Terms

Relias LLC FreeCME., Relias LLC., Hemophilia A Free CE CME

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map